{"id":2289,"date":"2023-10-18T11:25:22","date_gmt":"2023-10-18T11:25:22","guid":{"rendered":"http:\/\/www.bcgresearchcenter.cusri.chula.ac.th\/?p=2289"},"modified":"2023-10-18T11:25:22","modified_gmt":"2023-10-18T11:25:22","slug":"impact-of-covid-19-on-depressive-symptoms-among-patients-with-low-vision-and-blindness","status":"publish","type":"post","link":"http:\/\/www.bcgresearchcenter.cusri.chula.ac.th\/en\/impact-of-covid-19-on-depressive-symptoms-among-patients-with-low-vision-and-blindness\/","title":{"rendered":"Impact of COVID-19 on Depressive Symptoms Among Patients with Low Vision and Blindness."},"content":{"rendered":"
Abstract<\/b><\/p>\n
Background<\/span><\/p>\n Disability is globally recognized as a key cause of depression. Likewise, the COVID-19 pandemic has significantly increased the vulnerability of patients with low vision to health and health-related issues, especially mental health. This study aimed to examine the association between the impact of COVID-19 and depressive symptoms in patients with low vision and blindness.<\/span><\/p>\n Methods<\/span><\/p>\n This cross-sectional study was conducted between February and July 2022 and involved face-to-face interviews. Patients with low vision and blindness diagnosed with depression were excluded. The following items were included in the questionnaire: sociodemographic information, Multi-Dimensional Scale of Perceived Social Support (MSPSS), the impact of COVID-19, and The Center for Epidemiological Studies-Depression (CES-D). Hierarchical linear regression analysis was used to examine the association between the impact of COVID-19 and depression.<\/span><\/p>\n Results<\/span><\/p>\n The prevalence of depression among patients with low vision and blindness was 43.0%. Three factors were associated with depressive symptoms: compliance with COVID-19 prevention strategies (\u03b2 = 0.16, p<0.01), anxiety during COVID-19 (\u03b2 = 0.24, p<0.001), and social support (\u03b2 = \u22120.16, p<0.01).<\/span><\/p>\n Conclusion<\/span><\/p>\n The findings indicated that COVID-19 significantly increased depressive symptoms among patients with low vision and blindness. The psychological effects of the COVID-19 pandemic have been considered critical and emergent public health issues. Stakeholders, particularly <\/span>public health organizations, need to urgently implement preventive and protective measures to help patients with physical and mental disabilities.<\/span><\/p>\n","protected":false},"excerpt":{"rendered":" Abstract Background Disability is globally recognized as a key cause of depression. Likewise, the COVID-19 pandemic has significantly increased the vulnerability of patients with low vision to health and health-related issues, especially mental health. This study aimed to examine the association between the impact of COVID-19 and depressive symptoms in patients with low vision and<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[19],"tags":[],"class_list":["post-2289","post","type-post","status-publish","format-standard","hentry","category-journal"],"yoast_head":"\n